Enhancements Optimize Trial Management, Reduce Costs and Ease Investigative Site Burden
PHILADELPHIA– September 28, 2015 –– ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions today announced enhancements to MasterScope, its comprehensive platform for spirometry, ECG, and home monitoring, especially designed for both standardized and centralized clinical trials.
MasterScope delivers an all-in-one solution that meets and exceeds the data collection and processing needs of worldwide clinical trial sponsors and Clinical Research Organizations (CROs) in the development of medical treatments for respiratory conditions such as Asthma and COPD – and in non-respiratory areas such as oncology and CNS to collect pulmonary safety and disease progression endpoints.
The enhanced version of MasterScope introduces unique features that optimize data quality, trial management, reduce costs and shorten timelines for pharmaceutical sponsors and CROs while boosting investigative site satisfaction and efficiency. The benefits of the new features, which are not yet available from other vendors include:
- Multi-protocol support minimizing equipment costs and logistics, speeding up trial initiation and also easing investigative site burden with fewer devices to set up, maintain and take up physical space at the site
--Wireless Local Area Network (Wi-Fi) and LAN connectivity with automatic, secure data transfers to optimize centralized overreads and device software updates, ensuring the latest protocol amendments are in use
“We listened closely to pharmaceutical sponsors and investigative site personnel to identify the MasterScope enhancements that would best meet their needs,” said Achim Schülke, Executive Vice President, Respiratory Solutions at ERT. “With the industry’s most flexible solution for true multi-protocol support, device reuse and the new data transfer options available, MasterScope continues to be the most advanced platform of its kind for cardiopulmonary diagnostics, helping sites and sponsors to achieve the highest data quality with ease of use, efficiency and cost effectiveness.”
ERT will demonstrate MasterScope and other innovative solutions in Booth 1.E_05 at the European Respiratory Society (ERS) International Congress, September 26-30, 2015 in Amsterdam, Netherlands.
For more information on MasterScope, visit http://www.ert.com/respiratory/respiratory-innovative-solutions/.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.